$BCRX BIOCRYST PHARMACEUTICALS INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in BIOCRYST PHARMACEUTICALS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in BIOCRYST PHARMACEUTICALS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in BIOCRYST PHARMACEUTICALS INC for free.

CIK Number: 0000882796
IRS Number: 621413174
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: BCRX
Company Address: 4505 EMPEROR BOULEVARD SUITE 200 DURHAM 27703

BioCryst Pharmaceuticals, Inc. designs, optimizes and develops novel small molecule drugs that block key enzymes involved in the pathogenesis of diseases. Its drug candidates include rapivab, alpivab, rapiacta, peramiflu, BCX7353, BCX9930, BCX9250, Galidesivir, and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC.

Market Capitalization: $427.06M
Prev close: $5.67
Average Daily Volume: 981,787
Days Low: $5.55
Year Low: $1.63
Year High: $7.56

BIOCRYST PHARMACEUTICALS INC Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
ASELAGE STEVEDirector2,00011,340shares bought: 2,000 / shares sold: 0 BUYMar 14 20198 days ago
Babu Yarlagadda SSenior VP - Drug Discovery127,786724,547shares bought: 61,874 / shares sold: -71,106 SELLFeb 04 20192 months ago
Powell LynneSenior VP - CCO6,00034,020shares bought: 77,960 / shares sold: -106,659 SELLJan 29 20192 months ago
STAAB THOMAS R IISenior Vice President and CFO133,426756,525shares bought: 144,759 / shares sold: -155,074 SELLJan 30 20192 months ago
Stonehouse Jon PPresident & CEO724,1064,105,681shares bought: 127,376 / shares sold: -71,975 STRONG BUYJan 03 20193 months ago

View all BIOCRYST PHARMACEUTICALS INC insiders.

BIOCRYST PHARMACEUTICALS INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 14 2019BCRXBIOCRYST PHARMACEU ...ASELAGE STEVEDirectorBuyP8.302,00016,6002,0000 to 2 K
Feb 04 2019BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SSenior VP - Drug Di ...Option ExerciseM1.2012,18814,6260
Feb 04 2019BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SSenior VP - Drug Di ...Option ExerciseM1.2019,68623,6230
Feb 04 2019BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SSenior VP - Drug Di ...Payment of ExerciseF8.681,68514,626130,587132.3 K to 130.6 K (-1.27 %)
Feb 04 2019BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SSenior VP - Drug Di ...BuyM1.2012,18814,626132,272120.1 K to 132.3 K (+10.15 %)
Feb 04 2019BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SSenior VP - Drug Di ...Payment of ExerciseF8.687,70266,853120,084127.8 K to 120.1 K (-6.03 %)
Feb 04 2019BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SSenior VP - Drug Di ...BuyM1.2019,68623,623127,786108.1 K to 127.8 K (+18.21 %)
Jan 30 2019BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Option ExerciseM5.455,00027,2507,000
Jan 30 2019BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...SellS9.855,00049,250128,426133.4 K to 128.4 K (-3.75 %)
Jan 30 2019BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...BuyM5.455,00027,250133,426128.4 K to 133.4 K (+3.89 %)
Jan 29 2019BCRXBIOCRYST PHARMACEU ...Powell LynneSenior VP - CCOOption ExerciseM3.222,0006,44079,427
Jan 29 2019BCRXBIOCRYST PHARMACEU ...Powell LynneSenior VP - CCOOption ExerciseM3.224,00012,88081,427
Jan 29 2019BCRXBIOCRYST PHARMACEU ...Powell LynneSenior VP - CCOOption ExerciseM3.226,00019,32085,427
Jan 29 2019BCRXBIOCRYST PHARMACEU ...Powell LynneSenior VP - CCOSellS9.912,00019,82002 K to 0 (-100.00 %)
Jan 29 2019BCRXBIOCRYST PHARMACEU ...Powell LynneSenior VP - CCOBuyM3.222,0006,4402,0000 to 2 K

View all BIOCRYST PHARMACEUTICALS INC insider transactions.